IntelliPharmaCeutics Files Preliminary Base Shelf Prospectus And Shelf Registration Statement
5/21/2014 9:45:01 AM
TORONTO, May 20, 2014 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that it has filed a preliminary short form base shelf prospectus with securities regulatory authorities in each of the provinces and territories of Canada, except Quebec, and filed a registration statement with the United States Securities and Exchange Commission on Form F-3.
Help employers find you! Check out all the jobs and post your resume.
comments powered by